[go: up one dir, main page]

PE20071222A1 - Compuestos heterociclos como inhibidores de la proteasa de serina del virus de la hepatitis c - Google Patents

Compuestos heterociclos como inhibidores de la proteasa de serina del virus de la hepatitis c

Info

Publication number
PE20071222A1
PE20071222A1 PE2007000433A PE2007000433A PE20071222A1 PE 20071222 A1 PE20071222 A1 PE 20071222A1 PE 2007000433 A PE2007000433 A PE 2007000433A PE 2007000433 A PE2007000433 A PE 2007000433A PE 20071222 A1 PE20071222 A1 PE 20071222A1
Authority
PE
Peru
Prior art keywords
hepatitis
alkyl
compounds
virus
inhibitors
Prior art date
Application number
PE2007000433A
Other languages
English (en)
Inventor
Trixi Brandl
Sylvain Cottens
Claus Ehrhardt
Jiping Fu
Subramanian Karur
Hongju Li
Peichao Lu
David Thomas Parker
Michael Patane
Branko Radetich
Prakash Raman
Stefan Andreas Randl
Pascal Rigollier
Mohindra Seepersaud
Oliver Simic
Ritesh Bhanudasji
Yanyi Zhu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20071222A1 publication Critical patent/PE20071222A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60T—VEHICLE BRAKE CONTROL SYSTEMS OR PARTS THEREOF; BRAKE CONTROL SYSTEMS OR PARTS THEREOF, IN GENERAL; ARRANGEMENT OF BRAKING ELEMENTS ON VEHICLES IN GENERAL; PORTABLE DEVICES FOR PREVENTING UNWANTED MOVEMENT OF VEHICLES; VEHICLE MODIFICATIONS TO FACILITATE COOLING OF BRAKES
    • B60T17/00—Component parts, details, or accessories of power brake systems not covered by groups B60T8/00, B60T13/00 or B60T15/00, or presenting other characteristic features
    • B60T17/04—Arrangements of piping, valves in the piping, e.g. cut-off valves, couplings or air hoses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transportation (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Valves And Accessory Devices For Braking Systems (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA (I) DONDE x ES 0 O 1; y ES DE 0 A 2; R1, R2, R3, R7, R8, R9, R10, R11, R12, R13, R15, R16, R17, R22, V Y W SON CADA UNO ALQUILO(C1-C10), HETEROARILO DE HASTA 7 MIEMBROS, CICLOALQUILO(C4-C7), ALQUILOXILO, AMINO, ALQUILAMINO(C1-C10), ENTRE OTROS, OPCIONALMENTE SUSTITUIDO CON X1 Y X2, DONDE X1 ES ALQUILO(C1-C5), ALQUENILO(C2-C6), ALQUINILO(C2-C6), CICLOALQUILO(C3-C8), ENTRE OTROS; X2 ES OXO, ALQUILO(C1-C5), TIOALQUILO(C1-C6), NH2, CN, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: TERBUTIL-ESTER DEL ACIDO (3R,4R)-3-[(1R,2S)-1-(1H-INDOL-7-SULFONIL-AMINO-CARBONIL)-2-VINIL-CICLOPROPIL-CARBAMOIL]-4-FENETIL-PIRROLIDIN-1-CARBOXILICO, TERBUTIL-ESTER DEL ACIDO (3R,4R)-3-[(1R,2S)-1-(1H-INDOL-7-SULFONIL-AMINO-CARBONIL)-2-VINIL-CICLOPROPIL-CARBAMOIL]-4-(2-NAFTALEN-1-IL-ETIL)-PIRROLIDIN-1-CARBOXILICO, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE ADEMAS COMPRENDE UN INTERFERON, UN INHIBIDOR DE MONOOXIGENASA DEL CITOCROMO P450, ENTRE OTROS. DICHOS COMPUESTOS SON INHIBIDORES DE LA PROTEASA DE SERINA DEL VIRUS DE LA HEPATITIS C TAL COMO NS2 O NS3, LA HELICASA NS3, LA PROTEINA NS5a Y LA POLIMERASA NS5b SIENDO UTILES EN EL TRATAMIENTO DE HEPATITIS C, CIRROSIS HEPATICA, CARCINOMA HEPATOCELULAR
PE2007000433A 2006-04-11 2007-04-10 Compuestos heterociclos como inhibidores de la proteasa de serina del virus de la hepatitis c PE20071222A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79161106P 2006-04-11 2006-04-11

Publications (1)

Publication Number Publication Date
PE20071222A1 true PE20071222A1 (es) 2008-02-11

Family

ID=39590593

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000433A PE20071222A1 (es) 2006-04-11 2007-04-10 Compuestos heterociclos como inhibidores de la proteasa de serina del virus de la hepatitis c

Country Status (8)

Country Link
US (2) US7597406B2 (es)
KR (1) KR20080111127A (es)
CN (1) CN101466728A (es)
AR (1) AR060402A1 (es)
CL (1) CL2007001003A1 (es)
PE (1) PE20071222A1 (es)
RU (1) RU2008144298A (es)
TW (1) TW200815480A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8424977B2 (en) * 2008-06-09 2013-04-23 Mack Trucks, Inc. Front towing glad hands
US8123306B2 (en) * 2008-09-30 2012-02-28 Volvo Group North America, Llc Trailer connection selector
JP5010042B1 (ja) * 2011-06-10 2012-08-29 株式会社小松製作所 ダンプトラック
EP4419401A4 (en) * 2021-10-20 2025-08-27 Outrider Tech Inc TRAILER BRAKING VIA A TRAILER SUPPLY LINE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3241888A (en) * 1963-12-19 1966-03-22 Bendix Westinghouse Automotive Fluid pressure braking system
US3304131A (en) * 1964-08-27 1967-02-14 Wagner Electric Corp Protector valve for a trailer brake system
US3929381A (en) * 1974-03-11 1975-12-30 Midland Ross Corp Pneumatic brake system for a tractor-trailer vehicle including an anti-lock control valve in the trailer brake system
US3992064A (en) * 1975-12-04 1976-11-16 Wagner Electric Corporation Vehicle brake system
DE2861966D1 (en) * 1977-06-25 1982-09-16 Bendix Ltd Fluid pressure operable tractor and trailer vehicle braking systems
EP0387004A3 (en) * 1989-03-08 1990-11-22 LUCAS INDUSTRIES public limited company Trailer braking system for a towing vehicle
US5046786A (en) * 1990-06-12 1991-09-10 Midland Brake, Inc. Combination brake valve module
WO2004060734A1 (en) * 2002-12-31 2004-07-22 Bendix Commercial Vehicle Systems Llc Miniaturized dash valve system
MXPA05008991A (es) * 2003-02-24 2005-10-18 Bendix Commercial Vehicle Sys Sistema de valvula de enganche electro-neumatico.
GB2420840B (en) * 2004-12-03 2007-09-12 Trailer Checksafe Ltd Valve for inclusion in an emergency air supply line to the trailer braking system of an articulated vehicle

Also Published As

Publication number Publication date
TW200815480A (en) 2008-04-01
RU2008144298A (ru) 2010-05-20
KR20080111127A (ko) 2008-12-22
AR060402A1 (es) 2008-06-11
CL2007001003A1 (es) 2008-05-23
US7597406B2 (en) 2009-10-06
USRE44937E1 (en) 2014-06-10
CN101466728A (zh) 2009-06-24
US20070235275A1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
PE20091237A1 (es) Derivados de pirrolidina como moduladores de serina proteasas
ATE512971T1 (de) Peptidanaloga als hepatitis c-hemmer
PE20080072A1 (es) Compuestos heterociclicos como inhibidores de proteasas serinas
PE20121479A1 (es) Inhibidores del virus de la hepatitis c
PE20050999A1 (es) Cetoamidas novedosas con p4 ciclicos como inhibidores de ns3 serina proteasa del virus de hepatitis c
PE20051150A1 (es) Compuestos azufrados como inhibidores de la serina proteasa ns3 del virus de la hepatitis c
EA200802346A1 (ru) Циклопропилконденсированные индолобензазепиновые ингибиторы белка ns5b вируса гепатита с
TW200615275A (en) Hepatitis C inhibitor dipeptide analogs
PE20050940A1 (es) Nuevos inhibidores de la ns3/ns4a serina proteasa del virus de la hepatitis c
PE20070364A1 (es) Compuestos macrociclicos como inhibidores de la proteasa ns3 del virus de la hepatitis c
PE20080197A1 (es) Combinaciones que involucran el (los) inhibidor (es) de la proteasa del hcv, y metodos de tratamiento relacionado al (los) mismos(s)
CL2011002016A1 (es) Compuestos derivados de benzimidazol con actividad inhibidora de la funcion de la proteina ns5a codificada por el virus de la hepatitis c (vhc); composicion farmaceutica que los comprende; utiles en el tratamiento de una infeccion por el virus de la hepatitis c (vhc).
ATE547103T1 (de) Hemmer des hepatitis-c-virus
ATE492558T1 (de) Makrocyclische peptide als hepatitis-c-virus- hemmer
ATE532794T1 (de) Tripeptide als hemmer des hepatitis-c-virus
JP2010521483A5 (es)
PE20090648A1 (es) Compuestos para el tratamiento de la hepatitis c
ATE492559T1 (de) Makrocyclische peptide als hepatitis-c-virus- hemmer
JP2016518359A5 (es)
CL2004000076A1 (es) Compuestos derivados de indol, inhibidores de polimerasa, sales; composicion farmaceutica que los comprende; procedimiento de preparacion de dichos compuestos; compuestos intermediarios; y uso del compuesto para tratar una infeccion causada por el vi
PE20080677A1 (es) Inhibidores de pirrolotriazina cinaza
PE20090365A1 (es) Imidazopirazinas como inhibidores de proteina quinasa
JP2010515752A5 (es)
ATE483712T1 (de) Hcv-ns5b-inhibitoren
EA200900298A1 (ru) Ингибиторы вируса гепатита с

Legal Events

Date Code Title Description
FA Abandonment or withdrawal